Literature DB >> 383753

Immunohistochemical demonstration of basement membrane collagen in normal human skin and in psoriasis.

S Gay, T F Kresina, R Gay, E J Miller, L F Montes.   

Abstract

Antibodies prepared against the collagen C-chain derived from human placenta specifically strain the epidermal basement membrane of normal human skin as well as the basement membrane surrounding the skin appendages and capillaries. Using the antibodies, it was observed that all basement membranes in untreated psoriatic plaques appear fragmented and separted into several layers. The results suggest that psoriatic lesions are associated with a general loss of basement membrane integrity which may play a crucial role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383753     DOI: 10.1111/j.1600-0560.1979.tb01108.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Production and characterization of a monoclonal antibody to human Type IV collagen.

Authors:  L Y Sakai; E Engvall; D W Hollister; R E Burgeson
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

2.  Re-investigating the Basement Membrane Zone of Psoriatic Epidermal Lesions: Is Laminin-511 a New Player in Psoriasis Pathogenesis?

Authors:  Aki Natsumi; Koji Sugawara; Makiko Yasumizu; Yukari Mizukami; Shigetoshi Sano; Akimichi Morita; Ralf Paus; Daisuke Tsuruta
Journal:  J Histochem Cytochem       Date:  2018-06-15       Impact factor: 2.479

3.  Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation.

Authors:  J Hornung; A Bohnert; L Phan-Than; T Krieg; N E Fusenig
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Laminin, fibronectin, and collagen in synaptic and extrasynaptic portions of muscle fiber basement membrane.

Authors:  J R Sanes
Journal:  J Cell Biol       Date:  1982-05       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.